| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000040195 |
| Receipt No. | R000045836 |
| Scientific Title | Effects of educational tool on health behavior for weight reduction in middle aged workers with high body mass index and coronary risk factors: a pilot randomized controlled trial |
| Date of disclosure of the study information | 2020/04/19 |
| Last modified on | 2021/03/04 (Ver. 2) |
| Basic information | ||
| Public title | Development of educational tool to promote decision making for weight reduction in adults with body mass index >= 24 kg/m2 | |
| Acronym | Development of educational tool to promote decision making for weight reduction | |
| Scientific Title | Effects of educational tool on health behavior for weight reduction in middle aged workers with high body mass index and coronary risk factors: a pilot randomized controlled trial | |
| Scientific Title:Acronym | Effects of educational tool on health behavior for weight reduction in middle aged workers | |
| Region |
|
|
| Condition | ||
| Condition | diabetes mellitus, dyslipidemia and hypertension | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the effects of evidence-based individualized educational tool considering the subject's consciousness of disease and values on health behavior in middle aged workers with high body mass index and coronary risk factors. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | -Will of weight monitoring
-Will of dietary restriction for weight reduction -Will of exercise for weight reduction -Evaluation period: Before and after providing educational tool |
| Key secondary outcomes | -Physical activity
-Weight monitoring frequency -Dietary proclivity -Interest level for lifestyle modification(will of weight monitoring,will of dietary restriction for weight reduction, will of exercise for weight reduction) -Evaluation period: Before and at 1-month after providing educational tool |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | YES |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | Definition
Intervention: A group that receives individualized educational tool for weight reduction Note They receive educational tool to promote lifestyle modification for weight reduction individualized according to their coronary risk factors and questionnaire responses. |
|
| Interventions/Control_2 | Definition
Control: A group that receives standard educational tool for weight reduction Note Control: They receive standard educational tool to promote lifestyle modification for weight reduction. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | -Middle aged workers with body mass index >= 24 kg/m2
-Under treatment of diabetes mellitus, hypertension, dyslipidemia, or with one or more of the following: systolic blood pressure>=140mmHg; diastolic blood pressure>=90mmHg; triglyceride>=150mg/dL; low density lipoprotein cholesterol>=140mg/dL; high density lipoprotein cholesterol<40mg/dL; fasting plasma glucose>=126mg/dL; hemoglobin A1c>=6.5% -People who provide written informed consent |
|||
| Key exclusion criteria | Not applicable | |||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagoya University | ||||||
| Division name | Graduate School of Medicine (Health Sciences) | ||||||
| Zip code | 461-8673 | ||||||
| Address | 1-1-20 Daiko-Minami, Higashi-ku, Nagoya | ||||||
| TEL | 052-719-1346 | ||||||
| yamadas@met.nagoya-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagoya University | ||||||
| Division name | Graduate School of Medicine (Health Sciences) | ||||||
| Zip code | 461-8673 | ||||||
| Address | 1-1-20 Daiko-Minami, Higashi-ku, Nagoya | ||||||
| TEL | 052-719-1876 | ||||||
| Homepage URL | |||||||
| negishi.masaya@f.mbox.nagoya-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nagoya University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Epson health insurance society |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Ethics Committee of Nagoya University Graduate School of Medicine |
| Address | 65 Tsurumai-cho, Showa-ku, Nagoya |
| Tel | 052-744-2061 |
| ethics@med.nagoya-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 59 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045836 |